✦ LIBER ✦

Phase II Trial of Weekly Docetaxel/Gemcitabine as First-Line Chemotherapy in Patients with Locally Recurrent or Metastatic Breast Cancer

✍ Scribed by Joyce A. O'Shaughnessy; Robert Pluenneke; Jack Sternberg; Pankaj Khandelwal; Des Ilegbodu; Lina Asmar

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemcitabine as First-Line Therapy in Pat

✍ Blackstein, M.; Vogel, C.L.; Ambinder, R.; Cowan, J.; Iglesias, J.; Melemed, A. 📂 Article 📅 2002 🏛 S. Karger AG 🌐 English ⚖ 177 KB

Weekly paclitaxel as first-line chemothe

✍ A.J ten Tije; C.H Smorenburg; C Seynaeve; A Sparreboom; K.L.C Schothorst; L.G.M 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

First-line therapy with gemcitabine and

✍ Djelila Allouache; Sulochana R Gawande; Michele Tubiana-Hulin; Nicole Tubiana-Ma 📂 Article 📅 2005 🏛 BioMed Central 🌐 English ⚖ 275 KB

A phase II trial of docetaxel (Taxotere®

✍ Martina Baur; Allan T. van Oosterom; Véronique Diéras; Michele Tubiana-Hulin; R. 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 385 KB

Multicentric phase II trial of gemcitabi

✍ Cappuzzo, F; Mazzoni, F; Gennari, A; Donati, S; Salvadori, B; Orlandini, C; Cett 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 90 KB

The Breast Avastin Trial: phase II study

✍ Bisagni, G.; Musolino, A.; Panebianco, M.; Matteis, A.; Nuzzo, F.; Ardizzoni, A. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 256 KB